Focus Partners Wealth
HUMA icon

Focus Partners Wealth’s Humacyte HUMA Stock Holding History

Focus Partners Wealth’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.14K Buy
+13,420
New +$14K ﹤0.01% 2636
2025
Q3 		– Sell
-10,282
Closed -$21.5K – 2255
2025
Q2 		$21.5K Buy
+10,282
New +$19.8K ﹤0.01% 2004

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Focus Partners Wealth's HUMA Position: Q1 2026 in Review

Focus Partners Wealth opened a new position in Humacyte (HUMA) in Q1 2026: 13,420 shares worth $8.14K. The stake represents ﹤0.01% of the portfolio and ranks #2636 among its holdings. This is a return to the name: Focus Partners Wealth previously reported a position in HUMA as recently as Q2 2025.

Focus Partners Wealth first reported a position in HUMA in Q2 2025 and has held it in 2 quarters since. The position peaked at $21.5K in Q2 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Focus Partners Wealth held 13,420 shares of Humacyte worth $8.14K as of Q1 2026.
  • Humacyte was a new Focus Partners Wealth position in Q1 2026.
  • Humacyte made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #2636 holding.
  • Focus Partners Wealth first reported a position in Humacyte in Q2 2025 and has held it in 2 quarters since.
  • Focus Partners Wealth's Humacyte position peaked at $21.5K in Q2 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.